{"id":"NCT01457950","sponsor":"GlaxoSmithKline","briefTitle":"A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab","officialTitle":"A Six Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study With a Six Month Open-Label Extension to Evaluate the Efficacy and Safety of Denosumab in Korean Postmenopausal Women With Osteoporosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2012-12","completion":"2013-06","firstPosted":"2011-10-24","resultsPosted":"2013-10-29","lastUpdate":"2014-05-07"},"enrollment":135,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoporosis, Postmenopausal"],"interventions":[{"type":"DRUG","name":"denosumab","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"open-label denosumab","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"},{"label":"Arm 2","type":"PLACEBO_COMPARATOR"},{"label":"Arm 3","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine if denosumab is effective in increasing bone mineral density at the lumbar spine in Korean postmenopausal women with osteoporosis.","primaryOutcome":{"measure":"Mean Percent Change From Baseline in Lumbar Spine BMD at Month 6","timeFrame":"Baseline and Month 6","effectByArm":[{"arm":"Denosumab 60 mg","deltaMin":4.1,"sd":0.407},{"arm":"Placebo","deltaMin":0.89,"sd":0.413}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"60 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":22},"locations":{"siteCount":10,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":69},"commonTop":["Nasopharyngitis","Constipation","Myalgia","Dyspepsia","Ligament sprain"]}}